Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases

Evaluation of Outcomes From Treatment of Benign or Malignant Gastrointestinal Diseases

This study will be a retrospective, registry study collecting data of patients who were diagnosed with benign or malignant gastrointestinal diseases. Data will be collected from patient's chart retrospectively once the patients have completed proper treatment follow up with physicians' practice.

It is reported in the literature that the treatment of any gastrointestinal disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with gastrointestinal cancer continue to be diagnosed at an advanced stage with medical and surgical options that are improving in terms of outcome measurements but with much more room for improvement. The goal is to continue to review our treatment outcomes to further improve overall survival, overall symptom control, mortality and morbidity.

The main aim of this study is to evaluate and compare the outcomes from our treatment of benign or malignant gastrointestinal diseases through medical chart review.

There is a need to understand and improve the current diagnosis and treatment algorithm for gastrointestinal pathologies. Continued evaluation and study is imperative to ensure that national guidelines are improving to enhance patient cure and/or recovery.

Inclusion Criteria:

• All patients diagnosed and treated for gastrointestinal diseases, benign or malignant from 2005 to 2030.
• Age ≥18 years

Exclusion Criteria:

• Patients that are not diagnosed with or treated for gastrointestinal diseases
• Age <18 years